Science Explorer Back to mapMap
Discussion
Researcher · Dana-Farber Cancer Institute · United States

Kenneth J. Livak

Kenneth J. Livak publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Single-cell and spatial transcriptomics, CAR-T cell therapy research and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0001-9105-5856 OpenAlex
World rank
#89,751
of 7,710,434 ranked researchers
Rank in United States
#34,619
of 1,627,098
Works
441
Citations
260k
Citations per work
590.6
h-index
59
i10-index 101Top 2.1% in Molecular Biology
Kenneth J. Livak

What does Kenneth J. Livak research?

Kenneth J. Livak's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (16%), Immunology and Microbiology (12%).

Life Sciences: 235 works · 53.4% of their workBiochemistry, Genetics and Molecular Biology: 184 works · 41.7% of their workMolecular Biology: 164 works · 37.2% of their workCancer Research: 20 works · 4.5% of their workImmunology and Microbiology: 52 works · 11.7% of their workImmunology: 52 works · 11.7% of their workEverything else: 117 works · 26.5% of their workHealth Sciences: 69 works · 15.6% of their workMedicine: 69 works · 15.6% of their workOncology: 43 works · 9.8% of their workGenetics: 26 works · 5.8% of their workPhysical Sciences: 20 works · 4.5% of their workChemistry: 20 works · 4.5% of their workSpectroscopy: 20 works · 4.5% of their workTHEIR WORKKenneth J. Livak441works
Life Sciences53%Physical Sciences4%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology18441.7%
    2. Immunology and Microbiology5211.7%
  2. Everything else11726.5%
    1. Medicine6915.6%
    1. Chemistry204.5%
  1. 1Molecular Biology37% of their works
  2. 2Immunology12% of their works
  3. 3Oncology10% of their works
  4. 4Genetics6% of their works
  5. 5Spectroscopy4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Kenneth J. Livak's research?

The keywords of their largest research topics: Single-Cell, Transcriptomics, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Chronic Lymphocytic Leukemia, Genomic Aberrations and Mass Spectrometry.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Single-Cell941 topic
  2. Transcriptomics941 topic
  3. Cancer Immunotherapy572 topics
  4. CAR T Cells381 topic
  5. Chimeric Antigen Receptor381 topic
  6. Chronic Lymphocytic Leukemia371 topic
  7. Genomic Aberrations371 topic
  8. Mass Spectrometry311 topic
  9. Proteomics311 topic
  10. Cancer Genomics261 topic
  11. Mutational Signatures261 topic
  12. NK Cell Recognition211 topic
  13. Natural Killer Cells211 topic
  14. Immune Checkpoint Blockade201 topic
  15. PD-1 and PD-L1201 topic
  16. Dendritic Cells191 topic
  17. Immunity191 topic

Where does Kenneth J. Livak work?

Kenneth J. Livak's main affiliation in the publication record is Dana-Farber Cancer Institute, United States.

How many publications and citations does Kenneth J. Livak have?

OpenAlex counts 441 works and 260,434 citations for Kenneth J. Livak, an h-index of 59, ranking #89,751 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kenneth J. Livak. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.